Probiotic To Be Studied in People Living with HIV

A study will evaluate the safety, tolerability and effect of probiotics on the gut microbiome and immune activation markers in people living with HIV who are currently on suppressive antiretroviral therap.

ExeGi Pharma has announced participation in a clinical trial funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to study the probiotic Visbiome in people living with HIV. 

READ FULL ARTICLE Curated publisher From PR Newswire